Carboplatin Plus Docetaxel (Taxotere) in Anaplastic Prostate Cancer

NCT00514540 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

121

Enrollment

OTHER

Sponsor class

Conditions

Prostate Cancer

Interventions

DRUG: Docetaxel
DRUG: Carboplatin
DRUG: Etoposide
DRUG: Cisplatin

Sponsor

M.D. Anderson Cancer Center